NewGenIvf Group Limited (NIVF) 20-F2023 FY Annual report (foreign)

Filed: 19 Aug 24, 8:39pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

NIVF similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 16.1

August 19, 2024

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Ladies and Gentlemen:

We have read Item 16F of Form 20-F filed with the U.S. Securities and Exchange Commission on August 19, 2024 of NewGenIvf Group Ltd (the “Company”) and agree with the statements relating only to WWC, P.C. contained therein. We have no basis to agree or disagree with other statements of the Company contained therein.

We hereby consent to the filing of this letter as an exhibit to the foregoing report on Form 20-F.



/s/ WWC, P.C.
WWC, P.C.
Certified Public Accountants
PCAOB ID No.1171
San Mateo, California

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.